Fitzpatrick JM - Search Results

1

The identification and internal validation of a preoperative serum biomarker panel to determine extracapsular extension in patients with prostate cancer.

Oon SF, Fanning DM, Fan Y, Boyce S, Murphy TB, Fitzpatrick JM, Watson RW. Oon SF, et al. Among authors: fitzpatrick jm. Prostate. 2012 Oct 1;72(14):1523-31. doi: 10.1002/pros.22506. Epub 2012 Mar 13. Prostate. 2012. PMID: 22415934

2

Prostate cancer grading: the effect of stratification of needle biopsy Gleason Score 4 + 3 as high or intermediate grade.

Fanning DM, Kay E, Fan Y, Fitzpatrick JM, Watson RW. Fanning DM, et al. Among authors: fitzpatrick jm. BJU Int. 2010 Mar;105(5):631-5. doi: 10.1111/j.1464-410X.2009.08810.x. Epub 2009 Sep 3. BJU Int. 2010. PMID: 19732053

3

Applying random forests to identify biomarker panels in serum 2D-DIGE data for the detection and staging of prostate cancer.

Fan Y, Murphy TB, Byrne JC, Brennan L, Fitzpatrick JM, Watson RW. Fan Y, et al. Among authors: fitzpatrick jm. J Proteome Res. 2011 Mar 4;10(3):1361-73. doi: 10.1021/pr1011069. Epub 2011 Jan 27. J Proteome Res. 2011. PMID: 21166384

4

Epstein criteria for insignificant prostate cancer.

Oon SF, Watson RW, O'Leary JJ, Fitzpatrick JM. Oon SF, et al. Among authors: fitzpatrick jm. BJU Int. 2011 Aug;108(4):518-25. doi: 10.1111/j.1464-410X.2011.09979.x. Epub 2011 Feb 14. BJU Int. 2011. PMID: 21320276 Review.

5

Biomarker research in prostate cancer--towards utility, not futility.

Oon SF, Pennington SR, Fitzpatrick JM, Watson RW. Oon SF, et al. Among authors: fitzpatrick jm. Nat Rev Urol. 2011 Mar;8(3):131-8. doi: 10.1038/nrurol.2011.11. Nat Rev Urol. 2011. PMID: 21394176 Review.

6

Investigating the role of the IGF axis as a predictor of biochemical recurrence in prostate cancer patients post-surgery.

Breen KJ, O'Neill A, Murphy L, Fan Y, Boyce S, Fitzgerald N, Dorris E, Brady L, Finn SP, Hayes BD, Treacy A, Barrett C, Aziz MA, Kay EW, Fitzpatrick JM, Watson RWG. Breen KJ, et al. Among authors: fitzpatrick jm. Prostate. 2017 Sep;77(12):1288-1300. doi: 10.1002/pros.23389. Epub 2017 Jul 20. Prostate. 2017. PMID: 28726241

7

External validation of the 2007 and 2001 Partin tables in Irish prostate cancer patients.

Fanning DM, Fan Y, Fitzpatrick JM, Watson RW. Fanning DM, et al. Among authors: fitzpatrick jm. Urol Int. 2010;84(2):174-9. doi: 10.1159/000277594. Epub 2010 Mar 4. Urol Int. 2010. PMID: 20215821

8

Insulin-like growth factor I and prostate cancer.

O'Brien MF, Watson RW, Fitzpatrick JM. O'Brien MF, et al. Among authors: fitzpatrick jm. Urology. 2001 Jul;58(1):1-7. doi: 10.1016/s0090-4295(01)01004-4. Urology. 2001. PMID: 11445469 Review. No abstract available.

9

Novel predictive tools for Irish radical prostatectomy pathological outcomes: development and validation.

Fanning DM, Yue F, Fitzpatrick JM, Watson RW. Fanning DM, et al. Among authors: fitzpatrick jm. Ir J Med Sci. 2010 Jun;179(2):187-95. doi: 10.1007/s11845-009-0393-6. Epub 2009 Jul 14. Ir J Med Sci. 2010. PMID: 19597915

10

Detecting soluble clusterin in in-vitro and in-vivo models of prostate cancer.

Girard FP, Byrne J, Downes M, Fanning D, Desgrandchamps F, Fitzpatrick JM, Watson RW. Girard FP, et al. Among authors: fitzpatrick jm. Neoplasma. 2010;57(5):488-93. doi: 10.4149/neo_2010_05_488. Neoplasma. 2010. PMID: 20568904

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

540 results

Search Page

Filters